A. Čapek
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Fungal Biology and Applications
- Microbial Natural Products and Biosynthesis
-
- Steroid Chemistry and Biochemistry
- Enzyme Catalysis and Immobilization
Papers in
-
- Steroid Chemistry and Biochemistry 20
- Chemical Synthesis and Analysis 4
- Pharmacology 25
- Drug-Induced Adverse Reactions 16
- Fungal Biology and Applications 6
- Microbial Natural Products and Biosynthesis 4
- Co-authors
- O Hanč (22 shared papers)Jan Tůma (6 shared papers)B. Kakáč (6 shared papers)D. Perlman (4 shared papers)Karel Macek (2 shared papers)E. SVATEK (2 shared papers)Dana Němcová (3 shared papers)I. Ernest (1 shared paper)
- Journals
- Folia Microbiologica (44 papers)Die Naturwissenschaften (3 papers)The Journal of Antibiotics (1 paper)PubMed (6 papers)Chemischer Informationsdienst (1 paper)
- Partner nations
- CzechiaUnited States
In The Last Decade
A. Čapek
57 papers receiving 475 citations
Peers
Comparison fields: 5 of 60
- Pharmacology 158
- Pharmacology 108
- Molecular Biology 410
- Pharmaceutical Science 35
- Endocrinology, Diabetes and Metabolism 64
Countries citing papers authored by A. Čapek
This map shows the geographic impact of A. Čapek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Čapek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Čapek more than expected).
Fields of papers citing papers by A. Čapek
This network shows the impact of papers produced by A. Čapek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Čapek. The network helps show where A. Čapek may publish in the future.
Co-authors
The 14 scholars most cited alongside A. Čapek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1963 | 113 | |
| 2 | 1966 | 62 | |
| 3 | 1962 | 38 | |
| 4 | 1958 | 32 | |
| 5 | 1961 | 30 | |
| 6 | 1960 | 29 | |
| 7 | 1964 | 29 | |
| 8 | 1966 | 20 | |
| 9 | 1956 | 13 | |
| 10 | 1971 | 13 | |
| 11 | 1970 | 10 | |
| 12 | 1974 | 10 | |
| 13 | 1972 | 10 | |
| 14 | 1974 | 7 | |
| 15 | 1972 | 7 | |
| 16 | 1971 | 7 | |
| 17 | 1970 | 6 | |
| 18 | 1961 | 6 | |
| 19 | 1962 | 5 | |
| 20 | 1962 | 5 |
About A. Čapek
A. Čapek is a scholar working on Molecular Biology, Pharmacology, Organic Chemistry, Pharmaceutical Science and Ecology, Evolution, Behavior and Systematics, having authored 65 papers that have together received 547 indexed citations. Recurring topics across this work include Steroid Chemistry and Biochemistry (20 papers), Drug-Induced Adverse Reactions (16 papers), Fungal Biology and Applications (6 papers), Chemical Reactions and Isotopes (5 papers), Microbial Natural Products and Biosynthesis (4 papers), Chemical Synthesis and Analysis (4 papers), Nail Diseases and Treatments (3 papers) and Synthesis and biological activity (3 papers). The work is most often cited by research in Pharmacology (158 citations), Pharmacology (108 citations), Molecular Biology (410 citations), Pharmaceutical Science (35 citations) and Endocrinology, Diabetes and Metabolism (64 citations). A. Čapek has collaborated with scholars based in Czechia and United States. Frequent co-authors include O Hanč, Jan Tůma, B. Kakáč, D. Perlman, Karel Macek, E. SVATEK, Dana Němcová, I. Ernest, M. PROTIVA and J. O. Jílek. Their work appears in journals such as Folia Microbiologica, Die Naturwissenschaften, The Journal of Antibiotics, PubMed and Chemischer Informationsdienst.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.